These observations indicate that rcREG3A reduces the metabolic consequences of an unbalanced fatty diet, including the correction of dyslipidemia, by decreasing insulin secretion in response to glucose at a prediabetic stage. This evidence concerns the gene INS and metabolic syndrome.